ARTICLES BY THIS AUTHOR
- 8/2/2021
Upsher-Smith’s Anderson among Twin Cities’ 2021 Women in Business honorees
The Minneapolis/St. Paul Business Journal has named its Women in Business honorees, which include Cheryl Beal Anderson, vice president of global regulatory affairs at Upsher-Smith Labs. - 8/2/2021
ParaPRO intros Natroba
ParaPro's Natroba is the first product for scabies to be approved by the Food and Drug Administration in more than 30 years. - 8/2/2021
Camber intros new strength for generic Lioresal
Camber's generic Lioresal is now available in 5-, 10- and 20-mg dosage strengths. - 8/2/2021
MGA Report: Teva’s generics saved the U.S $28.8B in 2020
In the United States, Teva saved $28.8 billion in healthcare costs in 2020, $4.2 billion of which are savings to patients, according to a new independent study by Matrix Global Advisors. - 8/1/2021
AstraZeneca gets FDA nod for Saphnelo
Saphnelo is a monoclonal antibody administered by intravenous infusion to treat lupus. - 8/1/2021
Hy-Vee intros Hy-Vee Medicare Aisle for Medicare beneficiaries
Individuals aging into Medicare can now begin shopping and enrolling into Medicare plans through Hy-Vee Medicare Aisle, across its eight-state region. - 8/1/2021
NACDS receives ASAE's 2021 Power of A Gold award
NACDS is being recognized for its advocacy for policy changes at the state and federal levels that have empowered pharmacies’ COVID-19 response and helped protect patients. - 8/1/2021
Xiromed unveils generic Extina
The medication is the generic of Extina, which is used to treat a certain skin conditions, including seborrheic dermatitis. - 7/29/2021
Alembic unveils generic Levitra
Alembic’s generic Levitra comes in dosage strengths of 10 mg and 20 mg in 30-count bottles. - 7/28/2021
Lannett inks distribution agreement for generic Spiriva Handihaler
Spiriva Handihaler had a market value of $1.5 billion for the 12 months ended May 2021, although actual generic market values are expected to be lower.